HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, G. Articles by Matsumoto, Y. Search for Related Content PubMed PubMed Citation Articles by Kim, G. Articles by Matsumoto, Y.

Persistent Expression of Experimental Autoimmune Encephalomyelitis (EAE)-Specific Vß8.2 TCR Spectratype in the Central Nervous System of Rats with Chronic Relapsing EAE¹

Department of Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Monitoring the TCR repertoire is indispensable for the assessment of T cell-associated autoimmune diseases and subsequent TCR-based immunotherapy. In the present study, we examined the TCR repertoire of spinal cord T cells of Lewis rats by CDR3 spectratyping during chronic relapsing experimental autoimmune encephalomyelitis (EAE) induced by immunization with spinal cord homogenate. It was found that Vß8.2 spectratype with the shortest CDR3 expanded oligoclonally throughout the course of the disease. In addition, Vß12 spectratype expansion was observed at the first and second attacks of EAE. Sequence analysis revealed that clones with the DSSYEQYF sequence, which is a representative sequence of myelin basic protein (MBP)-reactive T cell clones, constituted the predominant population in the Vß8.2 family. Surprisingly, Vß12 also used the identical amino acid sequence in the CDR3 region. These findings indicate that although infiltrating T cells in the central nervous system are activated polyclonally, the TCR repertoire remains unchanged throughout the course. Moreover, the finding that the predominant CDR3 amino acid sequence of Vß8.2 and Vß12 spectratypes is identical with that of MBP-induced EAE suggests that a single Ag in spinal cord homogenate, possibly MBP, is involved in disease development.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Multiple sclerosis (MS)³ is a chronic progressive or relapsing remitting form of human autoimmune disease characterized by the presence of demyelinating plaques in the central nervous system (CNS). Several pieces of evidence suggest that T cells reactive with neuroantigens such as myelin basic protein (MBP) and proteolipid apoprotein are responsible for the development of MS lesions. However, controversial results have been reported so far with regard to the nature of MS-associated T cells for the following reasons (1, 2, 3). First, in contrast to inbred experimental animals, MHC haplotypes of humans are different among individuals. Therefore, the TCR phenotype of MS-associated T cells could be different from one person to another even if an Ag recognized by these T cells is the same. Second, it is difficult to obtain brain tissue, including MS plaques, for examination at an appropriate time point. When brain tissue obtained at autopsy is used, bystander T cells, which infiltrate the CNS at a later stage of the disease, may interfere with the analysis of MS-associated T cells. It is also possible that T cells recognizing an neuroantigen at a certain period would be substituted with those recognizing a different Ag as a result of inter- or intramolecular epitope spreading (4, 5).

We have recently applied CDR3 spectratyping for the analysis of oligoclonality of TCR of T cells which are responsible for the development of experimental autoimmune encephalomyelitis (EAE), an animal model for MS (6). In rat acute EAE, several groups including us reported that T cells bearing Vß8.2 TCR, which is frequently used by in vitro-established encephalitogenic T cell clones (7, 8), appear in the CNS parenchyma, especially at the early stage of the disease, and that a large number of these Vß8.2 TCR clones possess a common motif in their CDR3 region (9, 10, 11, 12). Based on these findings, we recently screened 22 spectratypes (Vß1–20) derived from T cells isolated from spinal cord lesions by CDR3 spectratyping and found that Vß8.2 spectratype with the shortest CDR3 is clonally expanded throughout the course of acute EAE (6). Furthermore, the EAE-specific nucleotide sequence is highly preserved in the CDR3 region. These results indicate that CDR3 spectratyping and subsequent sequencing of the CDR3 region of spectratype-derived TCR clones can be applicable for the detailed analysis of TCR of MS patients, the character of which is much more complicated than that of animal models as mentioned above.

In the present study, we performed CDR3 spectratyping analysis using spinal cord T cells and PBL isolated from rats with chronic relapsing EAE. Special attention was paid to the following points. First, is the EAE-specific spectratype pattern recognized in acute MBP-induced EAE also found in chronic relapsing EAE induced with spinal cord homogenate? Second, do changes in EAE-specific spectratype pattern occur in the course of chronic relapsing EAE? Consequently, it was found that EAE-specific spectratype pattern seen in acute EAE was also detectable in chronic relapsing EAE throughout the disease, suggesting that an encephalitogen in spinal cord homogenate is the same as that used for acute EAE induction. Thus, the determination of CDR3 size by spectratyping has been shown to be a powerful tool with which to analyze the T cell repertoire of T cell-mediated autoimmune diseases. Analysis of MS patients by CDR3 spectratyping may provide useful information about the nature of MS-associated T cells.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Rats and EAE induction

Lewis rats were purchased from Seiwa (Fukuoka, Japan) and used at 8–12 wk of age. Chronic relapsing EAE was induced by immunization of rats with 200 µl of guinea pig spinal cord homogenate in CFA (Mycobacterium tuberculosis H37Ra, 5 mg/ml) as described previously (13) with a few modifications. One gram of spinal cord tissue was homogenized in 1 ml of PBS, and the suspension was emulsified with an equal volume of CFA. Starting from the day of immunization, rats were given i.p. injections of cyclosporin A (Sandoz, Tokyo, Japan) at a dose of 4 mg/kg three times a week until day 21 postimmunization (PI). Acute EAE was induced by immunization with guinea pig MBP as described previously (14). Each rat was injected in the hind footpads on both sides with an emulsion containing 100 µg of guinea pig MBP in CFA. The clinical severity of EAE was divided into four stages (grade 1, floppy tail; grade 2, mild paraparesis; grade 3, severe paraparesis; grade 4, tetraparesis or moribund condition) (15). In this study, tissue sampling was performed at the early (day 10–12 PI), peak (day 13–15 PI), and recovery (day 21–23 PI) stages of acute EAE and at the first attack (day 14–17 PI), remission (day 20–23 PI), second attack (day 25–27 PI), and full recovery stage (day 34–37 PI) of chronic relapsing EAE. Under ether anesthesia, blood was aspirated via cardiac puncture, and the whole spinal cord was removed. PBL and spinal cord T cells were then isolated by proteolytic enzyme treatment and the density gradient method as described previously (16).

Immunohistochemical staining

A single immunoperoxidase staining was performed using mAbs against TCR Vß8.2 (R78), Vß8.5 (B73), and Vß10 (G101) (17) as described previously (14). Briefly, frozen sections of the spinal cord were air-dried and fixed in ether for 10 min. After incubation with normal horse serum, sections were allowed to react with mAb, biotinylated horse anti-mouse IgG (Vector, Burlingame, CA), and horseradish peroxidase (HRP)-labeled Vectstain Elite ABC Kit (Vector). HRP binding sites were detected in 0.005% diaminobenzidine and 0.01% hydrogen peroxide.

cDNA synthesis and PCR amplification

RNA was extracted from PBL and spinal cord T cells using RNAzol B (Biotecx Laboratories, Houston, TX). cDNA was then synthesized by reverse transcription with SuperScript Preamplification System (Life Technologies, Gaithersburg, MD) and amplified in a thermal cycler (Perkin-Elmer, Norwalk, CT) using primer pairs for TCR. Cycling conditions for PCR and nested PCR were as follows: 95°C for 10 min for denaturation and hot start, 55°C for 1 min for annealing, and 72°C for 1 min for extension followed by 40 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min. Primers for Vß1–20 were the same as those used in the previous study (9). Two types of Cß primers, Cß outer (5'-TGTTTGTCTGCGATCTCTGC-3') and Cß inner (5'-TCTGCTTCTGATGGCTCA-3'), were used in this study. Primers for V which were the same as those used in the previous study (18) and two types of C, C outer (5'-AGGGTGATGTTATCAGACTGG-3') and C inner (5'-GGATCTTTCAGCTGGTACACA-3'), were used for TCR -chain analysis. C and Cß primers were labeled with Cy-5 or rhodamine or remained unlabeled.

CDR3 spectratyping

CDR3 spectratyping was performed as described previously (19) with a few modifications. Three individual rats were examined at each time point. cDNA was amplified with V- or Vß-specific and rhodamine-labeled V or Cß outer primers, and undiluted or diluted PCR products were added to an equal volume of formamide/dye loading buffer and heated at 94°C for 2 min. Two microliters of the samples were applied to a 6% acrylamide sequencing gel. Gels were run at 30 W for 3 h 30 min at 50°C. Then, the fluorescence-labeled DNA profile on the gel was directly recorded using FMBIO fluorescence image analyzer (Hitachi, Yokohama, Japan). Spectratypes revealed by this analysis usually consisted of five to seven bands. We designated each band as I, II, or III in order of molecular size; e.g., the band representing the smallest Vß8.2 PCR products was Vß8.2 band I.

Sequencing of PCR products

cDNA in PCR products or isolated from bands (in most cases, band I) on the acrylamide gel was reamplified with Vß and unlabeled Cß inner primers. Then, PCR products were ligated into pT-Adv vector and cloned using the AdvanTAge PCR Cloning Kit (Clontech Laboratories, Palo Alto, CA) according to the manufacturer’s instructions. The plasmid DNA was then sequenced using Cy5-labeled Cß inner primer and Autoread Sequencing Kit on a ALFexpress DNA sequencer (Pharmacia Biotech, Tokyo, Japan). CDR3 length is defined as a region starting from an amino acid residue after the CASS sequence of most Vß segments and ending before the GXG box in the Jß region as described previously (20).

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Proportion of Vß8.2⁺, Vß8.5⁺, and Vß10⁺ T cells in the spinal cord at various stages of chronic relapsing EAE

In MBP-induced acute EAE, Vß8.2⁺ T cells are the predominant population in spinal cord T cells throughout the course of the disease (9). We wished to know whether Vß8.2 predominance is observed in chronic relapsing EAE induced by immunization with spinal cord homogenate. For this purpose, spinal cord sections taken from rats at various stages of EAE were immunohistochemically stained using currently available Vß-specific mAbs, and the proportion of Vß8.2⁺, Vß8.5⁺, and Vß10⁺ T cells was determined by counting stained cells. As shown in Fig. 1, Vß8.2⁺ T cells were the largest population among three phenotypes at all the stages examined. It is of interest to note that although the number of Vß8.5⁺ and Vß10⁺ T cells roughly paralleled the clinical course, that of Vß8.2⁺ T cells remained relatively unchanged during the remission, second attack and recovery stage after a steep decline after the first attack (Fig. 1).

View larger version (43K): [in this window] [in a new window]   FIGURE 1. Quantitative analysis of Vß8.2+, Vß8.5+, and Vß10+ T cells in chronic relapsing EAE. Spinal cord tissue was taken from rats at various stages, and immunohistochemical staining was performed using frozen sections. All positive cells in spinal cord sections were counted and expressed as the number of positive cells per section. At least six sections from three rats were examined at each time point.

For comparison, CDR3 spectratyping analysis was performed using T cells isolated from the spinal cord of a rat with MBP-induced acute EAE. A typical spectratype pattern is shown in Fig. 2. As reported previously (6) and confirmed here, oligoclonal expansion of Vß8.2 and Vß17 TCR with the shortest CDR3 (band I) (arrow and arrowhead in Fig. 2, respectively) was obvious at this stage. However, only Vß8.2 showed persistent expansion throughout the course of acute EAE (data not shown). Using spinal cord T cells isolated from rats during chronic relapsing EAE, CDR3 spectratyping was performed and the spectratype pattern was compared with that obtained in acute EAE (Fig. 3, A–D). It is clearly demonstrated that Vß8.2 band I was markedly expanded during the first attack (arrow in Fig. 3A). In addition, there was oligoclonal expansion of Vß12 band I (open arrow in Fig. 3A). Expansion of Vß8.2 band I persisted during the remission phase, while that of Vß12 band I was not recognized at this stage (Fig. 3B). In Fig. 3B, there was oligoclonal expansion of Vß19 band I (arrowhead), but this finding was observed only in one of three rats examined. The spectratype pattern at the second attack was similar to that at the first attack in which both Vß8.2 and Vß12 band I was clonaly expanded (arrow and open arrow in Fig. 3C). Vß8.2, but not Vß12, band I expansion was still noticed at the full recovery stage (Fig. 3D).

View larger version (58K): [in this window] [in a new window]   FIGURE 2. CDR3 spectratyping of TCR ß-chain of spinal cord T cells at the early stage of acute EAE. Total RNA was isolated from spinal cord T cells, reverse-transcribed into cDNA, and amplified with Vß1–20-specific and rhodamine-labeled Cß-specific primers. PCR products were run on a denaturating polyacrylamide gel and analyzed with a fluorescence image analyzer operated on a Macintosh computer. Spectratypes representing oligoclonal expansion of Vß8.2 and Vß17 cDNA with the shortest CDR3 are indicated by an arrow and an arrowhead, respectively.

View larger version (56K): [in this window] [in a new window]   FIGURE 3. CDR3 spectratyping of TCR ß-chain of spinal cord T cells at the first attack (A), remission (B), second attack (C), and full recovery stage (D) of chronic relapsing EAE.

View larger version (39K): [in this window] [in a new window]   FIGURE 4. CDR3 spectratyping of TCR -chain of spinal cord T cells at the first attack of chronic relapsing EAE.

We then extracted cDNA from Vß8.2 and Vß12 band I which showed oligoclonal expansion, amplified it by nested PCR, then cloned and determined the nucleotide sequences of the CDR3 region of each clone (Tables I and II). During the first attack, the most frequently found sequence in Vß8.2 band I was DSSYEQYF (58.3%) (Table I) which is reported to be the representative sequence of in vitro-established MBP-specific encephalitogenic T cell clone (7). The percentage of this sequence in Vß8.2 band I at the remission increased to 75% (Table I). Interestingly, the predominance of the DSSYEQYF sequence remained unchanged during the second attack and became more marked at the full recovery stage (Table I). We also sequenced the CDR3 region of clones derived from Vß12 band I (Table II) during the first and second attacks. Quite unexpectedly, the predicted amino acid sequence of the CDR3 region of the most frequently found Vß12 clones was identical to that of Vß8.2 clones, i.e., DSSYEQYF. However, the predominant Vß12 clone isolated at the first attack is not the same as that found at the second attack because the nucleotide sequence of these clones was different (Table II).

We also examined the spectratype pattern of TCR of PBL (Fig. 5). Since the CNS lacks the lymphatic system, precursor cells may enter the CNS via the blood stream. CDR3 size spectratyping was performed at the first attack, remission, second attack, and full recovery stages using PBL. Unlike spinal cord T cells, oligoclonal expansion was marked only in Vß8.2 TCR (data not shown). As shown in Fig. 5, Vß8.2 band I expansion was observed during the first and second attacks in PBL as seen in the spinal cord. However, this EAE-specific spectratype pattern was not visible in PBL at the remission and full recovery stage.

View larger version (27K): [in this window] [in a new window]   FIGURE 5. Profile of Vß8.2, Vß8.5, and Vß8.6 spectratypes of PBL and spinal cord T cells at the first attack, remission, second attack, and recovery stages of chronic relapsing EAE. Spectratypes of spinal cord T cells are the same as those of Fig. 3.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

We first determined the number of T cells bearing different Vß phenotypes using currently available Vß-specific mAbs (Fig. 1). As previously demonstrated by us (9) and others (10), Vß8.2⁺ T cells infiltrate the CNS at the early stage of MBP-induced acute EAE and become a predominant population. If Vß8.2 predominance is not observed in the spinal cord of rats with chronic relapsing EAE induced by immunization with spinal cord homogenate, then encephalitogenic Ags other than MBP would be involved. However, this was not the case. As clearly shown in this study, Vß8.2⁺ T cells are the predominant population throughout the course of chronic relapsing EAE, suggesting that Ag involved in chronic EAE is similar to that in acute EAE.

CDR3 spectratyping analysis revealed that EAE-specific spectratype pattern, i.e., oligoclonal expansion of Vß8.2 with the shortest CDR3 (band I), was found in the spinal cord throughout the course of chronic relapsing EAE and that it was essentially the same as that of acute monophasic EAE (6). Furthermore, determination of nucleotide and amino acid sequences showed that the CDR3 region of the majority of clones constituting Vß8.2 band I was the same as that of MBP-specific encephalitogenic T cell clones (7, 8) and remained unchanged as the disease progressed. The most straightforward explanation for these findings is that in chronic relapsing EAE of this type, encephalitogenic Ag is not switched from one to another and is similar to that of acute EAE, possibly MBP. Another characteristic finding was oligoclonal expansion of Vß12 band I of spinal cord T cells. Vß12 band I expansion was observed in the spinal cord, and not in PBL, only at the active stage of the disease (during the first and second attacks). Furthermore, the most frequently found CDR3 amino acid sequence was identical to that of Vß8.2. Although the exact function of T cells bearing this spectratype remained to be elucidated, we consider at the moment that they act as additional effector cells which are activated during active stages of chronic relapsing EAE. The possibility that they are regulatory T cells seems to be less likely because Vß12 band I expansion was not observed at the recovery stage. Collectively, these findings suggest that upon immunization with CNS homogenate including heterogeneous Ags, T cells recognize the major component of encephalitogens, expand and develop EAE lesions.

We have also examined TCR -chain by CDR3 spectratyping. Our previous studies regarding the V repertoire in acute EAE revealed that V1 and V2 expansion was observed at preclinical and early stages, whereas that of V23 was detected mainly at the clinical stages (G. Kim, K. Kohyama, N. Tamuma, and Y. Matsumoto, unpublished data). Thus, the use of V-chain by spinal cord T cells is not strict compared with that of Vß-chain. In the present study, we found that V6 and V23 showed oligoclonal expansion at the first and second attacks of chronic relapsing EAE. Therefore, preferential usage of V23 by spinal cord T cells is the same finding in both acute and chronic relapsing EAE although V6 expansion was not observed in acute EAE. These Vs are thought to pair with Vß8.2 or Vß12, which expanded oligoclonally in chronic relapsing EAE. However, it is also possible that multiple chains are expressed on a single cell as reported previously (21, 22). Very recently, Wang et al. (23) reported very interesting findings with regard to the role of TCR - and ß-chains in Ag specificity. Using mice carrying single V-chain (a TCR -chain transgenic mouse in a TCR -deficient background), they found that a specific amino acid residue of ß-chain plays a critical role in determining the specificity of TCR-Ag interactions. The fact that different TCR Vßs possess highly preserved sequences in the CDR3 region suggest that polyclonally activated T cells in the CNS recognize the same or structurally similar Ags during the course of the disease.

Analysis of PBL by CDR3 spectratyping also revealed an interesting finding with regard to relapse of EAE. As clearly shown in Fig. 5, Vß8.2 band I expansion in PBL was observed at the first and second attacks, but not at the remission and full recovery stage. In addition, the majority of TCR clones comprising this band possessed EAE-specific sequence in their CDR3 region (our unpublished data). These findings imply that encephalitogenic T cells are activated in the lymphoid organ and supplied via the blood stream to the CNS only during the clinical phase of the disease. Recently, it was demonstrated that myelin protein expression is increased in lymph node at a later stage of chronic relapsing EAE resulting in reactivation of encephalitogenic T cells (24). This event may correspond to reexpansion of Vß8.2 band I in PBL.

In the present study, we analyzed a complete set of TCR ß-chain family of spinal cord T cells and PBL of Lewis rats with chronic relapsing EAE by CDR3 spectratyping and then determined the nucleotide sequences of the spectratype-derived CDR3 of interest. We show here that EAE-specific spectratype pattern in the spinal cord remains unchanged throughout the course of the disease, thus strongly suggesting that encephalitogenic epitope recognized by T cells is not changed during the course. When considering TCR-based immunospecific therapy for MS patients, CDR3 spectratyping analysis is indispensable to obtain important information.

	Acknowledgments

 
We thank Y. Suzuki and Y. Kawazoe for technical assistance.

	Footnotes

 
¹ This study was supported in part by Grants-in-Aid 10357005, 09480216, and 09670682 from the Ministry of Education, Japan, and Toyama Chemical Co.

² Address correspondence and reprint requests to Dr. Yoh Matsumoto, Department of Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Musashidai 2-6 Fuchu, Tokyo 183-8526, Japan. E-mail address:

³ Abbreviations used in this paper: MS, multiple sclerosis; CNS, central nervous system; MBP, myelin basic protein; CDR3, complementarity-determining region 3; EAE, experimental autoimmune encephalomyelitis.

Received for publication March 24, 1998. Accepted for publication August 28, 1998.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Ben-Nun, A., R. S. Liblau, D. Lehmann, E. Tournier-Lasserve, A. Rosenzweig, Z. Jingwu, J. C. M. Raus, M.-A. Bach. 1991. Restricted T-cell receptor Vß gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc. Natl. Acad. Sci. USA 88:2466.[Abstract/Free Full Text]
2. Kotzin, B. L., S. Karuturi, Y. K. Chou, J. Lafferty, J. M. Forrester, M. Better, G. E. Nedwin, H. Offner, A. A. Vandenbark. 1991. Preferential T-cell receptor ß-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 88:9161.[Abstract/Free Full Text]
3. Wucherpfennig, K. W., J. Newcombe, H. Li, C. Keddy, L. Cuzner, D. A. Hafler. 1992. T cell receptor V-Vß repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 175:993.[Abstract/Free Full Text]
4. Lehmann, P. V., T. Forsthuber, A. Miller, E. E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155.[Medline]
5. Cross, A. H., V. K. Tuohy, C. S. Raine. 1993. Development of reactivity to new myelin antigen during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261.[Medline]
6. Kim, G., N. Tanuma, T. Kojima, K. Kohyama, Y. Suzuki, Y. Kawazoe, Y. Matsumoto. 1998. CDR3 size spectratyping and sequencing of spectratype-derived T cell receptor of spinal cord T cells in autoimmune encephalomyelitis. J. Immunol. 160:509.[Abstract/Free Full Text]
7. Gold, D. P., H. Offner, D. Sun, S. Wiley, A. A. Vandenbark, D. B. Wilson. 1991. Analysis of T cell receptor ß chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J. Exp. Med. 174:1467.[Abstract/Free Full Text]
8. Zhang, X., E. Heber-Katz. 1992. T cell receptor sequences from encephalitogenic T cells in adult Lewis rats suggest an early ontogenic origin. J. Immunol. 148:746.[Abstract]
9. Tsuchida, M., Y. Matsumoto, H. Hirahara, H. Hanawa, K. Tomiyama, T. Abo. 1993. Preferential distribution of Vß 8.2-positive cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 23:2399.[Medline]
10. Lannes-Vieira, J., J. Gehrmann, G. W. Kreutzberg, H. Wekerle. 1994. The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rats: distinct nature of parenchymal and perivascular infiltrates. Acta Neuropathol. 87:435.[Medline]
11. Buenafe, A. C., A. D. Weinberg, N. E. Culbertson, A. A. Vandenbark, H. Offner. 1996. Vß CDR3 motif associated with BP recognition are enriched in OX-40⁺ spinal cord T cells of Lewis rats with EAE. J. Neurosci. Res. 44:562.[Medline]
12. Matsumoto, Y., S. Abe, M. Tsuchida, H. Hirahara, T. Abo, T. Shin, N. Tanuma, T. Kojima, Y. Ishihara. 1996. Characterization of CD4^-CD8^- TCRß⁺ T cells appearing in the subarachnoid space of rats with autoimmune encephalomyelitis. Eur. J. Immunol. 26:1328.[Medline]
13. Polman, D. H., I. Matthaei, C. J. A. d. Groot, J. C. Koetsier, T. Sminia, C. D. Dijkstra. 1988. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 17:209.[Medline]
14. Ohmori, K., Y. Hong, M. Fujiwara, Y. Matsumoto. 1992. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis: evidence suggesting that most infiltrating T cells do not proliferate in the target organ. Lab. Invest. 66:54.[Medline]
15. Matsumoto, Y., M. Fujiwara. 1987. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. I. Immunohistochemical examination of developing lesion of EAE. J. Neurol. Sci. 77:35.[Medline]
16. Tanuma, N., T. Kojima, T. Shin, Y. Aikawa, T. Kohji, Y. Ishihara, Y. Matsumoto. 1997. Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J. Neuroimmunol. 73:197.[Medline]
17. Torres-Nagel, N. E., D. P. Gold, T. Hünig. 1993. Identification of rat Tcrb-V8.2, 8.5, and 10 gene products by monoclonal antibodies. Immunogenetics 37:305.[Medline]
18. Buenafe, A. C., R. C. Tsu, Jr B. Bebo, A. C. Bakke, A. A. Vandenbark, H. Offner. 1997. A TCR V CDR3-specific motif associated with Lewis rat autoimmune encephalomyelitis and basic protein-specific T cell clones. J. Immunol. 158:5472.[Abstract]
19. Gorski, J., M. Yassai, X. Zhu, B. Kissella, C. Keever, N. Flomenberg. 1994. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. J. Immunol. 152:5109.[Abstract]
20. Rock, E. P., P. R. Sibbald, M. M. Davis, Y.-H. Chien. 1994. CDR3 length in antigen-specific immune receptors. J. Exp. Med. 179:323.[Abstract/Free Full Text]
21. Heath, W. R., J. F. A. P. Miller. 1993. Expression of two chains on the surface of T cells in T cell receptor transgenic mice. J. Exp. Med. 178:1807.[Abstract/Free Full Text]
22. Padovan, E., G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, A. Lanzavecchia. 1993. Expression of two T cell receptor chains: dual receptor T cells. Science 262:422.[Abstract/Free Full Text]
23. Wang, F., T. Ono, A. Kalergis, W. Zhang, T. P. DiLorenzo, K. Lim, S. G. Nathenson. 1998. On defining the rules for interactions between the T cell receptor and its ligand: a critical role for a specific amino acid residue of the T cell receptor ß chain. Proc. Natl. Acad. Sci. USA 95:5217.[Abstract/Free Full Text]
24. Mackenzie-Graham, A. J., T. M. Pribyl, S. Kim, V. R. Porter, A. T. Campagnoni, R. R. Voskuhl. 1997. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J. Immunol. 159:4602.[Abstract]

This article has been cited by other articles:

				H. Sakuma, K. Kohyama, Y. Jee, and Y. Matsumoto Tracking of V{beta}8.2-Positive Encephalitogenic T Cells by Complementarity-Determining Region 3 Spectratyping and Subsequent Southern Blot Hybridization in Lewis Rats after Neuroantigen Sensitization J. Immunol., October 1, 2004; 173(7): 4516 - 4522. [Abstract] [Full Text] [PDF]

				A. Miyakoshi, W. K. Yoon, Y. Jee, and Y. Matsumoto Characterization of the Antigen Specificity and TCR Repertoire, and TCR-Based DNA Vaccine Therapy in Myelin Basic Protein-Induced Autoimmune Encephalomyelitis in DA Rats J. Immunol., June 15, 2003; 170(12): 6371 - 6378. [Abstract] [Full Text] [PDF]

				Y. Matsumoto, W. K. Yoon, Y. Jee, K. Fujihara, T. Misu, S. Sato, I. Nakashima, and Y. Itoyama Complementarity-Determining Region 3 Spectratyping Analysis of the TCR Repertoire in Multiple Sclerosis J. Immunol., May 1, 2003; 170(9): 4846 - 4853. [Abstract] [Full Text] [PDF]

				Y. Okura, Y. Jee, and Y. Matsumoto Acquired thymic tolerance to autoimmune encephalomyelitis is associated with activation of peripheral IL-10-producing macrophages/dendritic cells Int. Immunol., March 1, 2003; 15(3): 437 - 446. [Abstract] [Full Text] [PDF]

				M. A. Haque, T. Mizobuchi, K. Yasufuku, T. Fujisawa, R. R. Brutkiewicz, Y. Zheng, K. Woods, G. N. Smith, O. W. Cummings, K. M. Heidler, et al. Evidence for Immune Responses to a Self-Antigen in Lung Transplantation: Role of Type V Collagen-Specific T Cells in the Pathogenesis of Lung Allograft Rejection J. Immunol., August 1, 2002; 169(3): 1542 - 1549. [Abstract] [Full Text] [PDF]

				T.-J. Huang, P. A. MacAry, P. Eynott, A. Moussavi, K. C. Daniel, P. W. Askenase, D. M. Kemeny, and K. F. Chung Allergen-Specific Th1 Cells Counteract Efferent Th2 Cell-Dependent Bronchial Hyperresponsiveness and Eosinophilic Inflammation Partly Via IFN-{{gamma}} J. Immunol., January 1, 2001; 166(1): 207 - 217. [Abstract] [Full Text] [PDF]

				Y. Matsumoto, Y. Jee, and M. Sugisaki Successful TCR-Based Immunotherapy for Autoimmune Myocarditis with DNA Vaccines After Rapid Identification of Pathogenic TCR J. Immunol., February 15, 2000; 164(4): 2248 - 2254. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, G. Articles by Matsumoto, Y. Search for Related Content PubMed PubMed Citation Articles by Kim, G. Articles by Matsumoto, Y.